| Specialty Retail Industry | Consumer Discretionary Sector | Marco Alfonsi CEO | OTC PINK Exchange | 63108T105 CUSIP |
| US Country | 12 Employees | - Last Dividend | - Last Split | - IPO Date |
Nascent Pharma Holdings, Inc. is a dynamic company focused on the protection and commercialization of cannabis-related patents. Established in 2005 and based in Hicksville, New York, the company underwent a rebranding from Can B Corp. to its current name in September 2025. This strategic shift reflects its expanded ambitions within the rapidly evolving cannabis market, emphasizing innovation and the development of proprietary technologies. By leveraging its intellectual property, Nascent Pharma aims to carve a niche in the competitive landscape while addressing the growing consumer demand for cannabis-based products.
Nascent Pharma Holdings, Inc. specializes in protecting cannabis patents, ensuring that its innovative products and processes are safeguarded against infringement. This service is crucial for maintaining competitive advantage and fostering innovation in the cannabis industry.
The company actively seeks to commercialize its cannabis-related technologies, enabling other businesses to utilize its patented innovations. By partnering with various entities, Nascent Pharma facilitates the growth and expansion of cannabis products in the market.
Under the Longevity brand, Nascent Pharma offers superfood drink mix products that are formulated to provide health benefits derived from cannabis and other nutritional ingredients. These products cater to health-conscious consumers looking for functional food options that contribute to overall wellness.